Genetic testing serves as a valuable tool for shedding light on the molecular mechanisms underlying SQTS, identifying mutations in genes like KCNH2, KCNJ2, and KCNQ1, which result in a gain of function for potassium channels, leading to accelerated repolarization of the cardiac action potential. This evidence concerns the gene KCNH2 and Familial short QT syndrome.